Medicare Beneficiary Out-of-Pocket Costs for Generic Cardiovascular Medications Available Through $4 Generic Drug Discount Programs

Ann Intern Med. 2018 Dec 4;169(11):817-819. doi: 10.7326/M18-0965. Epub 2018 Jul 24.

Authors

Patrick Liu¹, Sanket S Dhruva², Nilay D Shah³, Joseph S Ross⁴

Affiliations

¹ Yale School of Medicine, New Haven, Connecticut (P.L.).
² Yale School of Medicine and Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut (S.S.D.).
³ Mayo Clinic, Rochester, Minnesota (N.D.S.).
⁴ Yale School of Medicine, Yale University School of Public Health, and Yale-New Haven Hospital, New Haven, Connecticut (J.S.R.).

PMID: 30039170
DOI: 10.7326/M18-0965

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

Cardiovascular Agents / therapeutic use*
Community Pharmacy Services / economics*
Cost Savings / economics
Drugs, Generic / economics*
Humans
Medicare / economics*
Prescription Fees*
United States

Substances

Cardiovascular Agents
Drugs, Generic